In-N-Out Burger CEO to join the list of high-profile business figures to leave California
'There are a lot of great things about California, but raising a family is not easy here,' Snyder announced last week on the 'Relatable' podcast, hosted by conservative commentator Allie Beth Stuckey. 'Doing business is not easy here.'
Snyder said the corporate headquarters will remain in California. The company announced in 2023 that it planned to open a corporate office in Tennessee, along with restaurants in and around Nashville.
With her move to Tennessee, Snyder becomes the latest high-profile business figure to decamp a state known for its sunshine but also heavy taxes and regulation, progressive politics and a punishing cost of living.
Other departures have included Charles Schwab and Chevron, which cited regulatory issues, taxes and high operating costs, and Elon Musk announced last year he was moving the headquarters of SpaceX and social media company X to Texas. He said at the time that a California law barring school districts from requiring staff to notify parents of their child's gender identification change was the 'final straw.'
Snyder is the granddaughter of the chain's founder, Harry Snyder, who opened his first drive-thru hamburger stand in Southern California in 1948. The California cachet has long been part of the brand's identity.
According to its website, In-N-Out Burger has over 400 locations across eight states — California, Nevada, Arizona, Utah, Texas, Oregon, Colorado and Idaho.
In a post on the social media platform X, Tennessee Gov. Bill Lee said, 'From the first time I met Lynsi and her team, we both knew (the chain) would thrive in the Volunteer State.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Here's What to Expect From AutoZone's Next Earnings Report
Valued at a market cap of $64.1 billion, AutoZone, Inc. (AZO) retails and distributes automotive replacement parts and accessories. The Memphis, Tennessee-based company provides various products for cars, sport utility vehicles, vans, and light trucks, including new and remanufactured automotive hard parts, maintenance items, accessories, and non-automotive products. It is expected to announce its fiscal Q4 earnings for 2025 on Tuesday, Sept. 23. Ahead of this event, analysts project this automotive replacement parts company to report a profit of $51.42 per share, up 6.9% from $48.11 per share in the year-ago quarter. The company has missed Wall Street's bottom-line estimates in each of the last four quarters. Its earnings of $35.36 per share in Q3 fell short of the consensus estimates by 3.9%. More News from Barchart Tesla Just Signed a Chip Supply Deal with Samsung. What Does That Mean for TSLA Stock? Dear Microsoft Stock Fans, Mark Your Calendars for Aug. 1 Is Lucid Motors Stock a Buy, Sell, or Hold for July 2025? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For the full year, analysts expect AZO's EPS to be $147.67, up 1.1% from $146.14 per share in fiscal 2024. Its EPS is expected to further grow 14.2% year-over-year (YoY) to $168.64 in fiscal 2026. Shares of AutoZone have outpaced the S&P 500 Index's ($SPX) 17.1% return over the past 52 weeks, with its shares up 22.9% over the same time frame. However, it has lagged behind the Consumer Discretionary Select Sector SPDR Fund's (XLY) 23.9% uptick over the same period. AutoZone's shares plunged 3.4% on May 27, after it delivered its Q3 earnings results. While its revenue rose 5.4% YoY to $4.5 billion, beating estimates, net income slipped 3.6% annually to $35.36 per share, missing the mark by 3.9% - signaling a mixed bag of growth and pressure. Despite the top-line growth, higher costs of sales and increased operating expenses weighed on its profitability, dampening investor confidence. Wall Street analysts are highly optimistic about AZO's stock, with an overall "Strong Buy" rating. Among 26 analysts covering the stock, 21 recommend a "Strong Buy," two indicate a "Moderate Buy," and three advise a 'Hold.' The mean price target for AZO is $4,125.46, indicating an 8.7% potential upside from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
3 hours ago
- Yahoo
Boeing posts smaller loss as jet deliveries rise
(Reuters) -Boeing reported a smaller second-quarter loss on Tuesday as the U.S. planemaker ramped up jet production and deliveries, recovering from a regulatory crisis and a major strike that halted most production last year. Shares of the company rose 1.5% in premarket trading. After years of grappling with quality issues and production delays on its flagship 737 MAX, Boeing has cautiously ramped up monthly output this year. In May, the company produced 38 737s. Production has been stable since then, according to the company. "As we continue to execute our Safety & Quality Plan, there's more stability in our operations," CEO Kelly Ortberg said in a letter to Boeing employees on Tuesday. The U.S. Federal Aviation Administration had capped the production of Boeing's best selling 737 MAX jets following a mid-air panel blowout in a nearly new jet in January 2024. "We plan to seek FAA approval to increase to rate 42 when our key performance indicators (KPIs) show that we're ready," Ortberg added. It has delivered 206 737 MAX jets through the first half of the year. Wall Street closely tracks aircraft deliveries, because planemakers collect much of their payment when they hand over jets to customers. Boeing also increased 787 production at its plant in Charleston, South Carolina, from five aircraft a month to seven a month. Through the first half of the year, the planemaker has booked 668 orders, or 625 net orders after cancellations and conversions. An improvement in deliveries marks a pivotal step in Boeing's effort to rebound from years of production disruptions and crises that piled on debt, highlighting the urgency of accelerating output to restore financial stability. The planemaker posted a net loss of $612 million, or 92 cents per share, for the quarter through June, compared with $1.44 billion, or $2.33 per share, a year earlier. However, the planemaker continues to face pressure from supply chain disruptions that have delayed production and limited its ability to meet surging aerospace demand. It posted a loss of nearly $12 billion in 2024 due to challenges across its major business units including charges on its defense programs. It also remains exposed to U.S. President Donald Trump's sweeping tariffs, which could increase parts costs and further strain an already fragile supply chain. Boeing's revenue for the quarter through June rose 35% to $22.75 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
